Weekly Recap: FDA approval for Parkinson’s therapy and Enchant v3 AI pact

AbbVie, Inc. (NYSE:ABBV) is expanding its footprint across therapies and tech—winning FDA approval for a Parkinson’s drug and Canadian approval for Epkinly while launching Allergan Aesthetics’ SKIN360 and partnering with Iambic on AI-driven drug discovery—yet faces U.S. probe requests about China t…